Cashu
Entero Therapeutics Innovates Gut-Targeted Solutions for Gastrointestinal Disorders
about 21 hours ago
Stocks
Health Care
grdx
Entero Therapeutics
NASDAQ: GRDX
+0.48 (+18.63%)
3.025
USD
At close at Dec 26, 21:40 UTC
Overview
Loading chart...
Key Stats
Market Cap
4.73M
Dividend Yield
0.00%
P/E Ratio
-0.30
EPS
-4.67
Revenue
-
Avg. Volume
112.38K
About
What does GRDX do?
First Wave Biopharma, headquartered in Boca Raton, Florida, develops nonsystemic therapies for gastrointestinal diseases and went public in October 2016. Its key programs include latiglutenase, capeserod, and adrulipase.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.